Top Markets
#1 Islamic Coin Islamic Coin +152.30%
#2 Bitway Bitway +48.48%
#3 Starpower Starpower +39.10%
#4 aelf aelf +28.38%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +28.38%
#6 SkyAI SkyAI +21.40%
#7 Pons Pons +16.95%
#8 DAPPOS DAPPOS +14.12%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#10 Decred Decred +14.08%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Rang in Aktien #29654
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Aktienkurs
$0.68377137
Zuletzt synchronisiert: 2023-05-23
Marktkapitalisierung
$20.23M
Veränderung (1 Tag)
-0.60%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Medivir AB (publ) (MVIR-B)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Medivir AB (publ) (MVIR-B)
Dividendenrendite (TTM) von Medivir AB (publ) (Aktienkürzel: MVIR-B) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Medivir AB (publ) (MVIR-B) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR